Assessment of Irregular Bleeding in Primary Care. Mr Tyrone Carpenter MD MRCOG Consultant Obstetrician & Gynaecologist Poole Hospitals NHS Trust

Similar documents
Abnormal Uterine Bleeding FAQ Sheet

Update on Abnormal Uterine Bleeding. Susan M. Sheridan, M.D., F.A.C.O.G Casper Obstetrical and Gynecological Associates Casper, WY

Abnormal Uterine Bleeding: Simple evaluation and management in premenopausal women

Heavy periods (menstrual bleeding)

Histopathological Pattern of Endometrial Sampling Performed for Abnormal Uterine Bleeding. Layla S Abdullah, MD, FRCPC* Nabeel S Bondagji, MD, FRCSC**

POST MENOPAUSAL BLEEDING CHECKLIST. Ultrasound. Information folder given to patient. Booking form faxed/ ed

Abnormal Uterine Bleeding

Medical criteria for IUCD s Based on the WHO MEC (2004- Annexure 3) system a woman s eligibility for IUCD insertion falls in 4 categories. These categ

Kate O Hanlan, M. D. F. A. C. O. G., F. A. C. S.

Genital Tract Cancers in Females: Endometrial Cancer

Ovarian cysts Diagnosis and Management

Introduction Ovarian cysts are a very common female condition. An ovarian cyst is a fluid-filled sac on an ovary in the female reproductive system.

Gynecology Abnormal Pelvic Anatomy and Physiology: Cervix. Cervix. Nabothian cysts. cervical polyps. leiomyomas. Cervical stenosis

Dysfunctional Uterine Bleeding

Gynecologic Cancer in Women with Lynch Syndrome

K Raja/N Varol FPA FPA Sydney August

Polycystic ovary syndrome: what it means for your long-term health

Polyps. Hyperplasias. CAP 2011: Course AP104. The High Risk Benign Endometrium. Mutter and Nucci 1

Uterus myomatosus. 10-May-15. Clinical presentation. Incidence. Causes? 3 out of 4 women. Growth rate vary. Most common solid pelvic tumor in women

Ovarian Cyst. Homoeopathy Clinic. Introduction. Types of Ovarian Cysts. Contents. Case Reports. 21 August 2002

Abnormal Uterine Bleeding. Howard Herrell, MD FACOG

Screening for ovarian cancer Page 1 of 5 Ovacome

Hereditary Breast and Ovarian Cancer (HBOC)

Polycystic Ovarian Syndrome

Role of Hysteroscopy and Laparoscopy in Evaluation of Abnormal Uterine Bleeding

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

worry When to Cervical Abnormalities CME Workshop What s the situation? What are the trends? By Dianne Miller, MD, FRCSC In this article:

Reproductive Health Group

Clinical Practice Guidance for the Assessment of Young Women aged with Abnormal Vaginal Bleeding

Understanding Your Risk of Ovarian Cancer

Fact sheet 9. Screening for ovarian cancer

Are You at Risk for Ovarian Cancer?

Breast Imaging Made Brief and Simple. Jane Clayton MD Associate Professor Department of Radiology LSUHSC New Orleans, LA

1.Management of Abnormal Uterine Bleeding

OUTPATIENT HYSTEROSCOPY SERVICES JASMINE SUITE

Abigail R. Proffer, M.D. October 4, 2013

Information for you Abortion care

Implantation Clinic Health

Introduction to Gynecologic Oncology

MODERN EVALUATION OF THE ENDOMETRIUM

Why I don t recommend endometrial ablation

Uterine Fibroid Symptoms, Diagnosis and Treatment

There are many different types of cancer and sometimes cancer is diagnosed when in fact you are not suffering from the disease at all.

NOTTINGHAM UNIVERSITY HOSPITAL NHS TRUST NOTTINGHAM BREAST INSTITUTE BREAST AND OVARIAN FAMILY HISTORY GUIDELINES

3 Summary of clinical applications and limitations of measurements

Frequently Asked Questions About Ovarian Cancer

The Benign Endometrial Hyperplasia Sequence

The menstrual cycle Hypophysis

Hull & East Riding Prescribing Committee

Menopause and Hormone Replacement Therapy

Evaluation and Management of the Breast Mass. Gary Dunnington,, M.D. Department of Surgery Internal Medicine Ambulatory Conference December 4, 2003

U.K. Familial Ovarian Cancer Screening Study (UK FOCSS) Phase 2 Patient Information Sheet

Uterine Cancer. Understanding your diagnosis

Out-patient hysteroscopy. Information for patients

Cervical cancer in 2 women with a Mirena : a pitfall in the assessment of irregular bleeding

Nicole Kounalakis, MD

PROVERA (medroxyprogesterone acetate) Product Monograph Page 34 of 38

Thyroid Dysfunction in Dysfunctional Uterine Bleeding

What are the differences between fibroid and ovarian cyst?

The Scottish Public Services Ombudsman Act 2002

Saint Mary s Hospital. Ovarian Cysts. Information For Patients

Office of Population Health Genomics

Screening for Cancer in Light of New Guidelines and Controversies. Christopher Celio, MD St. Jude Heritage Medical Group

TAMOXIFEN, A NONCORTICOSTEROIDAL partial

NORTHAMPTONSHIRE INTEGRATED SEXUAL HEALTH SERVICES IUD/IUS PROTOCOL

Cervical Cancer The Importance of Cervical Screening and Vaccination

Cervical Cancer Screening and Management Guidelines: Changing Again, Huh?

From update.co.uk one day courses for GPs, by GPs

Management of Abnormal PAP Smears. K Chacko, MD, FACP 2010 GIM Conference

WELCOME TO COLLEGE HEIGHTS OBGYN ASSOCIATES

Cancer Facts for Women

POLYCYSTIC OVARY SYNDROME

Menstruation and the Menstrual Cycle

Pleural and Pericardial fluids a one year analysis

Global Market for Women s Health Devices to Reach $2.4 Billion by 2021

OVARIAN CYSTS. Types of Ovarian Cysts There are many types of ovarian cysts and these can be categorized into functional and nonfunctional

HIRSUTISM. What are the aims of this leaflet?

Acute pelvic inflammatory disease: tests and treatment

Follow-Up Care for Breast Cancer

Thyroid Dysfunction in Dysfunctional Uterine Bleeding

RBH GUIDELINES FOR ULTRASOUND REFERRAL

Treating heavy menstrual bleeding caused by fibroids or polyps

Three-Dimensional Inversion Rendering

PRENATAL/WOMEN S HEALTH ROTATION

WOMENCARE A Healthy Woman is a Powerful Woman (407) Ovarian Cysts

Gynaecology FAQ s. Correspondence address: 204 Fulham Road London SW10 9PJ Tel:

Overview of Gynaecologic Cancer

Thyroid Dysfunction in Dysfunctional Uterine Bleeding

How To Treat A Uterine Sarcoma

Intermenstrual and postcoital bleeding

Examples of good screening tests include: mammography for breast cancer screening and Pap smears for cervical cancer screening.

Breast Cancer Follow-Up

Full version is >>> HERE <<<

A Guide to Hysteroscopy. Patient Education

Ovarian Cysts Made Simple Michael East. Oxford Clinic

Pap smears, cytology and CCHC lab work and follow up

Why would you need a hysterectomy?

Reduced Ovarian Reserve Is there any hope for a bad egg?

POSTMENOPAUSAL ASSESS AND WHAT TO DO

Uterine fibroids (Leiomyoma)

Transcription:

Assessment of Irregular Bleeding in Primary Care Mr Tyrone Carpenter MD MRCOG Consultant Obstetrician & Gynaecologist Poole Hospitals NHS Trust

Outline What s normal Differential Diagnosis Risk factors for cancer Investigations available Suggested investigations in primary care Summary

What is normal? Normal Abnormal Cycle length Duration of bleeding Volume of blood loss Regular 21-35 days 3-7 days 30-40ml Irregular Greater than 7 days >80ml

The size of the problem 4-10% incidence of abnormal bleeding 5% of GP consultations 1998 UK 7 million in GP prescriptions

Differential Diagnosis (1) Endometrial Dysfunctional Uterine Bleeding Ovulatory Anovulatory Polyps Hyperplasia Carcinoma (IUCD / IUS)

Differential Diagnosis (2) Other genital abnormality Cervical Carcinoma Extra genital abnormality Thyroid dysfunction

Endometrial polyps

Proportion of Polyps by Age Uncommon < 35yo Over 1/2 between 35-55yo

Malignant Risk of Polyps Vast majority <55yo are benign

Endometrial Hyperplasia Simple -? Increased risk of Ca (2-3%) Complex - Slight increase risk Ca (3-4%) Complex Atypical 10-20% may have current underlying Ca 24-50% may develop Ca

Endometrial Carcinoma Around 10% of endometrial Ca occurs pre-menopausally

Risk Factors for Endometrial Carcinoma / Hyperplasia High BMI Nulliparity Late menopause Polycystic ovarian syndrome Personal or family history of Ca Colon / Breast / Endometrial / Ovarian Tamoxifen

Risk related to age <40yo DUB most likely by far Polyps next most likely by vast majority benign in this age group Only 1-3% of all endometrial Ca occurs <40yo Hyperplasia more likely than Ca by still uncommon in this age group Obviously risk factors play a part.

Investigation of Irregular History Examination Bleeding Speculum +/- smear if due Bimanual (limited use but can pick up big fibroids, ovarian cysts etc.) Investigations

Investigations available Pelvic Ultrasound scan Pipelle endometrial sample (or similar) Hysteroscopy + endometrial biopsy

Transvaginal Ultrasound Scan Advantages No risk V little discomfort Usually picks up polyps Disadvantages No histology

Transvaginal Ultrasound

Pipelle Endometrial Sampler Advantages Histology obtained (usually) Disadvantages May miss polyps Occasionally misses hyperplasia / Ca Sometimes fails Can be uncomfortable

Pipelle Endometrial Sampler

Hysteroscopy + Endometrial Biopsy Advantages Can identify (and treat) polyps Can identify Ca Disadvantage Requires hospital referral May need GA Can still miss some Ca

So who should be Ix and how far should we go in Primary Care? < 40yo with no risk factors no need to investigate as first line. If significant risk factors investigated as >40yo If fails medical treatment the investigation required

So who should be Ix and how far should we go in Primary Care? > 40yo requires investigation Stage of referral depends on local situation Perfectly reasonable to obtain a scan and take a pipelle (if properly trained) in primary care

Possible Results - Ultrasound Normal Undertake pipelle sample Polyp Identified / Suspected Refer

Possible Results - Histology Normal proliferative / secretory / menstrual endometrium Simple / Complex hyperplasia without atypia Complex atypical hyperplasia Carcinoma Insufficient for analysis

Action on abnormal histology Simple / Complex hyperplasia without atypia Commence 10mg Provera od and routine referal to Gynae Complex atypical hyperplasia Carcinoma Insufficient for analysis Either repeat or refer routinely Urgent Gynae referral

Summary Irregular bleeding is common The vast majority of women < 40yo will have no sinister pathology and don t require immediate investigation Most women >40yo will have no significant pathology but do require investigation USS and pipelle sampling can be undertaken in a primary care setting in most cases